uniQure (QURE) Change in Acquisitions & Divestments (2023 - 2026)
uniQure's (QURE) quarterly Change in Acquisitions & Divestments came in at $98.7 million in Q1 2026, up 16.12% year-on-year from $85.0 million in Q1 2025, and down 20.04% quarter-over-quarter from $123.4 million in Q3 2025.
uniQure (QURE) Change in Acquisitions & Divestments (2023 - 2026) Analysis & Trends
uniQure's Change in Acquisitions & Divestments history runs 4 years deep, the most recent figure standing at $98.7 million for Q1 2026.
- On a quarterly basis, Change in Acquisitions & Divestments rose 16.12% year-over-year to $98.7 million in Q1 2026; TTM through Mar 2026 was $350.9 million, a 25.24% decrease from a year earlier, with the FY2025 full-year figure at $337.2 million, down 36.91% from the prior year.
- Change in Acquisitions & Divestments eased to $98.7 million in Q1 2026 per QURE's latest filing, from $123.4 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $183.0 million in Q3 2024 and bottomed at $5.3 million in Q1 2023.
- The 4-year median for Change in Acquisitions & Divestments is $91.8 million (2025), against an average of $94.9 million.
- Across the five-year window, Change in Acquisitions & Divestments jumped 2716.27% in 2024 and slumped 43.37% in 2025, its largest moves.
- Year by year, Change in Acquisitions & Divestments stood at $61.6 million in 2023, then fell by 12.84% to $53.7 million in 2024, then surged by 129.89% to $123.4 million in 2025, then dropped by 20.04% to $98.7 million in 2026.
- Per Business Quant, the three latest QURE Change in Acquisitions & Divestments figures stand at $98.7 million (Q1 2026), $123.4 million (Q3 2025), and $128.8 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | uniQure | 2.41 Bn | 2.41 Bn | 3.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 98.70 Mn |
| Mar 31, 2026 | 98.70 Mn |
| Sep 30, 2025 | 123.43 Mn |
| Sep 30, 2025 | 123.43 Mn |
| Jun 30, 2025 | 128.76 Mn |
| Jun 30, 2025 | 128.76 Mn |
| Mar 31, 2025 | 85.00 Mn |
| Mar 31, 2025 | 85.00 Mn |
| Dec 31, 2024 | 53.69 Mn |
| Dec 31, 2024 | 53.69 Mn |
| Sep 30, 2024 | 183.00 Mn |
| Sep 30, 2024 | 183.00 Mn |
| Jun 30, 2024 | 147.70 Mn |
| Jun 30, 2024 | 147.70 Mn |
| Mar 31, 2024 | 150.11 Mn |
| Mar 31, 2024 | 150.11 Mn |
| Dec 31, 2023 | 61.60 Mn |
| Dec 31, 2023 | 61.60 Mn |
| Sep 30, 2023 | 54.07 Mn |
| Sep 30, 2023 | 54.07 Mn |